| Schedule of Segment Information |
The following tables present our segment information for the 13 and 26 weeks ended July 1, 2023 and July 2, 2022 (in $000’s):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thirteen Weeks Ended |
|
Twenty-Six Weeks Ended |
|
July 1, 2023 |
|
July 2, 2022 |
|
July 1, 2023 |
|
July 2, 2022 |
| Revenues |
|
|
|
|
|
|
|
| Biotechnology |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Discontinued operations |
— |
|
|
10,538 |
|
|
3,795 |
|
|
19,862 |
|
| Total Revenues |
$ |
— |
|
|
$ |
10,538 |
|
|
$ |
3,795 |
|
|
$ |
19,862 |
|
| Gross profit |
|
|
|
|
|
|
|
| Biotechnology |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Discontinued operations |
— |
|
|
1,649 |
|
|
(197) |
|
|
3,502 |
|
| Total Gross profit |
$ |
— |
|
|
$ |
1,649 |
|
|
$ |
(197) |
|
|
$ |
3,502 |
|
| Operating income (loss) |
|
|
|
|
|
|
|
| Biotechnology |
$ |
(1,060) |
|
|
$ |
(658) |
|
|
$ |
(2,159) |
|
|
$ |
(1,339) |
|
| Discontinued operations |
— |
|
|
9,639 |
|
|
14,159 |
|
|
9,229 |
|
| Total Operating income (loss) |
$ |
(1,060) |
|
|
$ |
8,981 |
|
|
$ |
12,000 |
|
|
$ |
7,890 |
|
| Depreciation and amortization |
|
|
|
|
|
|
|
| Biotechnology |
$ |
362 |
|
|
$ |
— |
|
|
$ |
726 |
|
|
$ |
2 |
|
| Discontinued operations |
— |
|
|
135 |
|
|
96 |
|
|
268 |
|
| Total Depreciation and amortization |
$ |
362 |
|
|
$ |
135 |
|
|
$ |
822 |
|
|
$ |
270 |
|
| Interest (income) expense, net |
|
|
|
|
|
|
|
| Biotechnology |
$ |
(365) |
|
|
$ |
(167) |
|
|
$ |
(840) |
|
|
$ |
(165) |
|
| Discontinued operations |
— |
|
|
807 |
|
|
181 |
|
|
418 |
|
| Total Interest expense, net |
$ |
(365) |
|
|
$ |
640 |
|
|
$ |
(659) |
|
|
$ |
253 |
|
| Net income (loss) before income taxes |
|
|
|
|
|
|
|
| Biotechnology |
$ |
62 |
|
|
$ |
(227) |
|
|
$ |
(827) |
|
|
$ |
2,392 |
|
| Discontinued operations |
1 |
|
|
9,105 |
|
|
13,976 |
|
|
7,700 |
|
| Total Net income before income taxes |
$ |
63 |
|
|
$ |
8,878 |
|
|
$ |
13,149 |
|
|
$ |
10,092 |
|
|